Items where contributor is "Medinger, Michael"
2016Ecsedi, Matyas and Schmohl, Jörg and Zeiser, Robert and Drexler, Beatrice and Halter, Jörg and Medinger, Michael and Duyster, Justus and Kanz, Lothar and Passweg, Jakob and Finke, Jürgen and Bethge, Wolfgang and Lengerke, Claudia. (2016) Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation. Annals of hematology, 95 (10). pp. 1627-1636. Medinger, Michael and Heim, Dominik and Gerull, Sabine and Halter, Jörg and Krenger, Werner and Buser, Andreas and Lengerke, Claudia and Bucher, Christoph and Passweg, Jakob. (2016) Increase of endothelial progenitor cells in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia. Leukemia Research, 47. pp. 22-25. Medinger, Michael and Halter, Jörg and Heim, Dominik and Buser, Andreas and Gerull, Sabine and Lengerke, Claudia and Passweg, Jakob. (2016) Gene-expression Profiling in Patients with Plasma Cell Myeloma Treated with Novel Agents. Cancer genomics & proteomics, 13 (4). pp. 275-279. Medinger, Michael and Lengerke, Claudia and Passweg, Jakob. (2016) Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia. Cancer Genomics & Proteomics, 13 (5). pp. 317-329. Baumgartner, Annic and Zueger, Noemi and Bargetzi, Annika and Medinger, Michael and Passweg, Jakob R. and Stanga, Zeno and Mueller, Beat and Bargetzi, Mario and Schuetz, Philipp. (2016) Association of Nutritional Parameters with Clinical Outcomes in Patients with Acute Myeloid Leukemia Undergoing Haematopoietic Stem Cell Transplantation. Annals of Nutrition & Metabolism, 69 (2). pp. 89-98. 2015Medinger, Michael and Krenger, Werner and Jakab, A. and Halter, Jörg and Buser, Andreas and Bucher, Christoph and Passweg, Jakob and Tzankov, Alexandar. (2015) Numerical impairment of nestin(+) bone marrow niches in acute GvHD after allogeneic hematopoietic stem cell transplantation for AML. Bone marrow transplantation, 50 (11). pp. 1453-1458. Tschan-Plessl, A. and Halter, Jörg and Heim, Dominik and Medinger, Michael and Passweg, Jakob and Gerull, Sabine. (2015) Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation. Annals of hematology, 94 (11). pp. 1899-1905. Binkert, L. and Medinger, Michael and Halter, Jörg and Heim, Dominik and Gerull, Sabine and Holbro, A. and Lengerke, C. and Weisser, M. and Passweg, Jakob. (2015) Lower dose anti-thymocyte globulin for GvHD prophylaxis results in improved survival after allogeneic stem cell transplantation. Bone marrow transplantation, 50 (10). pp. 1331-1336. Passweg, Jakob and Schanz, U. and Chalandon, Y. and Güngör, T. and Baldomero, H. and Heim, Dominik and Nair, G. and Medinger, Michael and Masouridi-Levrat, S. and de Faveri, G. N. and Tiercy, J.-M. and Swiss Blood Stem Cell Transplantation Group, . (2015) High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities. Bone marrow transplantation, 50 (9). pp. 1201-1205. Medinger, Michael and Halter, Jörg and Heim, Dominik and Buser, Andreas and Gerull, Sabine and Stern, Martin and Passweg, Jakob. (2015) Angiogenic markers in plasma cell myeloma patients treated with novel agents. Anticancer research, 35 (2). pp. 1085-1090. Schäfer, Claudia and O'Meara, Alix and Tsakiris, Dimitrios A. and Medinger, Michael and Passweg, Jakob R. and Stern, Martin. (2015) Influence of selective serotonin reuptake inhibitors on bleeding risk in patients with severe thrombocytopenia after chemotherapy: a retrospective study. Acta Haematologica, 133 (3). pp. 317-320. 2014Medinger, Michael and Passweg, Jakob. (2014) Role of tumour angiogenesis in haematological malignancies. Swiss medical weekly, 144. w14050. Gerull, Sabine and Medinger, Michael and Heim, Dominik and Passweg, Jakob and Stern, Martin. (2014) Evaluation of the pretransplantation workup before allogeneic transplantation. Biology of blood and marrow transplantation, 20 (11). pp. 1852-1856. Mross, Klaus and Büchert, Martin and Frost, Annette and Medinger, Michael and Stopfer, Peter and Studeny, Matus and Kaiser, Rolf. (2014) Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis. BMC cancer, 14. p. 510. Tzankov, Alexandar and Medinger, Michael. (2014) Aplastic anemia: possible associations with lymphoproliferative neoplasms. International journal of laboratory hematology, 36 (3). pp. 382-387. Rueff, Jessica and Medinger, Michael and Heim, Dominik and Passweg, Jakob and Stern, Martin. (2014) Lymphocyte subset recovery and outcome after autologous hematopoietic stem cell transplantation for plasma cell myeloma. Biology of blood and marrow transplantation, 20 (6). pp. 896-899. O'Meara, Alix and Holbro, Andreas and Meyer, Sara and Martinez, Maria and Medinger, Michael and Buser, Andreas and Halter, Jörg and Heim, Dominik and Gerull, Sabine and Bucher, Christoph and Rovo, Alicia and Kühne, Thomas and Tichelli, André and Gratwohl, Alois and Stern, Martin and Passweg, Jakob R.. (2014) Forty years of haematopoietic stem cell transplantation: a review of the Basel experience. Swiss medical weekly, 144. w13928. Meyer, Sara C. and Medinger, Michael and Halter, Jörg P. and Baldomero, Helen and Hirsch, Hans H. and Tzankov, Alexandar and Dirnhofer, Stephan and Passweg, Jakob R. and Tichelli, André. (2014) Heterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation. Hematology, 19 (5). pp. 280-285. Medinger, Michael and Passweg, Jakob. (2014) Angiogenesis in myeloproliferative neoplasms, new markers and future directions. memo - Magazine of European Medical Oncology, 7. pp. 206-210. Medinger, Michael and Muesser, Patricia and Girsberger, Sabine and Skoda, Radek and Tzankov, Alexandar and Buser, Andreas and Passweg, Jakob and Tsakiris, Dimitrios Α. (2014) Dkk3 levels in patients with myeloproliferative neoplasms. Thrombosis Research, 133 (2). pp. 218-221. Bürgler, David and Medinger, Michael and Passweg, Jakob and Fischmann, Arne and Bucher, Christoph. (2014) Intra-arterial catheter guided steroid administration for the treatment of steroid-refractory intestinal GvHD. Leukemia Research, 38 (2). pp. 184-187. 2013Pircher, Andreas and Fiegl, Michael and Untergasser, Gerold and Heidegger, Isabel and Medinger, Michael and Kern, Johann and Hilbe, Wolfgang. (2013) Favorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs). Lung Cancer, 81 (2). pp. 252-258. Medinger, M. and Tichelli, A. and Bucher, C. and Halter, J. and Dirnhofer, S. and Rovo, A. and Passweg, J. and Tzankov, A.. (2013) GVHD after allogeneic haematopoietic SCT for AML: angiogenesis, vascular endothelial growth factor and VEGF receptor expression in the BM. Bone Marrow Transplantation, 48 (5). pp. 715-721. 2012Gavillet, M. and Medinger, M. and Tichelli, A. and Fux-Arnold, C.. (2012) Neutropenia and fever of unknown origin. PRAXIS, 101 (24). pp. 1573-1576. Sigle, Joerg-Peter and Medinger, Michael and Stern, Martin and Infanti, Laura and Heim, Dominik and Halter, Joerg and Gratwohl, Alois and Buser, Andreas. (2012) Prospective change control analysis of transfer of platelet concentrate production from a specialized stem cell transplantation unit to a blood transfusion center. Journal of Clinical Apheresis, 27 (4). pp. 178-182. Medinger, Michael and Buser, Andreas and Stern, Martin and Heim, Dominik and Halter, Jörg and Rovo, Alicia and Tzankov, Alexandar and Tichelli, André and Passweg, Jakob. (2012) Aplastic anemia in association with a lymphoproliferative neoplasm: coincidence or causality? Leukemia Research, 36 (2). pp. 250-251. 2011Pircher, Andreas and Hilbe, Wolfgang and Heidegger, Isabel and Drevs, Joachim and Tichelli, André and Medinger, Michael. (2011) Biomarkers in tumor angiogenesis and anti-angiogenic therapy. International journal of molecular sciences, Vol. 12, H. 10. pp. 7077-7099. Medinger, Michael and Saller, Elisabeth and Harteveld, Cornelis L. and Lehmann, Thomas and Graf, Lukas and Rovo, Alicia and Buser, Andreas and Passweg, Jakob and Tichelli, André. (2011) A rare case of coinheritance of Hemoglobin H disease and sickle cell trait combined with severe iron deficiency. Hematology reports, 3 (3). e30. Pircher, Andreas and Medinger, Michael and Drevs, Joachim. (2011) Liver cancer: Targeted future options. World Journal of Hepatology, 3 (2). pp. 38-44. Medinger, M. and Esser, N. and Soltau, J. and Lehmann, K. M. and Konerding, M. A. and Wolloscheck, T. and Ryan, A. J. and Drevs, J.. (2011) Antitumor effect of the vascular-disrupting agent ZD6126 in a murine renal cell carcinoma model. International journal of oncology, 38 (2). pp. 455-464. 2010Drevs, Joachim and Medinger, Michael and Mross, Klaus and Fuxius, Stefan and Hennig, Juergen and Buechert, Martin and Thomas, Anne and Unger, Clemens and Chen, Bee-Lian and Lebwohl, David and Laurent, Dirk. (2010) A phase IA, open-label, dose-escalating study of PTK787/ZK 222584 administered orally on a continuous dosing schedule in patients with advanced cancer. Anticancer Research, 30 (6). pp. 2335-2339. Medinger, Michael and Mross, Klaus. (2010) Clinical trials with anti-angiogenic agents in hematological malignancies. Journal of Angiogenesis Research, 2 (1). p. 10. Medinger, Michael and Kleinschmidt, Manuela and Mross, Klaus and Wehmeyer, Barbara and Unger, Clemens and Schaefer, Hans-Eckart and Weber, Renate and Azemar, Marc. (2010) c-kit (CD117) expression in human tumors and its prognostic value: an immunohistochemical analysis. Pathology Oncology Research, 16 (3). pp. 295-301. 2009Medinger, Michael and Esser, Norbert and Zirrgiebel, Ute and Ryan, Anderson and Jürgensmeier, Juliane M. and Drevs, Joachim. (2009) Antitumor and antiangiogenic activity of cediranib in a preclinical model of renal cell carcinoma. Anticancer Research, 29 (12). pp. 5065-5076. Medinger, Michael and Skoda, Radek and Gratwohl, Alois and Theocharides, Alexandre and Buser, Andreas and Heim, Dominik and Dirnhofer, Stephan and Tichelli, André and Tzankov, Alexandar. (2009) Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status. British Journal of Haematology, 146 (2). pp. 150-157. 2008Buser, A. and Stern, M. and Arber, C. and Medinger, M. and Halter, J. and Rovo, A. and Favre, G. and Lohri, A. and Tichelli, A. and Gratwohl, A.. (2008) Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab? Bone Marrow Transplantation, 42 (7). pp. 483-487. 2007Steinbild, Simone and Arends, Jann and Medinger, Michael and Häring, Brigitte and Frost, Annette and Drevs, Joachim and Unger, Clemens and Strecker, Ralph and Hennig, Jürgen and Mross, Klaus. (2007) Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients--results of a phase II study. Onkologie, 30 (12). pp. 629-635. Unger, Clemens and Häring, Brigitte and Medinger, Michael and Drevs, Joachim and Steinbild, Simone and Kratz, Felix and Mross, Klaus. (2007) Phase I and pharmacokinetic study of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin. Clinical Cancer Research, 13 (16). pp. 4858-4866. Drevs, Joachim and Siegert, Patrizia and Medinger, Michael and Mross, Klaus and Strecker, Ralph and Zirrgiebel, Ute and Harder, Jan and Blum, Hubert and Robertson, Jane and Jürgensmeier, Juliane M. and Puchalski, Thomas A. and Young, Helen and Saunders, Owain and Unger, Clemens. (2007) Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumors. Journal of Clinical Oncology, 25 (21). pp. 3045-3054. 2005Mross, Klaus and Drevs, Joachim and Müller, Marianne and Medinger, Michael and Marmé, Dieter and Hennig, Jürgen and Morgan, Bruno and Lebwohl, David and Masson, Eric and Ho, Yu-Yun and Günther, Clemens and Laurent, Dirk and Unger, Clemens. (2005) Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours. European Journal of Cancer, 41 (9). pp. 1291-1299. Medinger, Michael and Drevs, Joachim. (2005) Receptor tyrosine kinases and anticancer therapy. Current Pharmaceutical Design, 11 (9). pp. 1139-1149. Drevs, J. and Zirrgiebel, U. and Schmidt-Gersbach, C. I. M. and Mross, K. and Medinger, M. and Lee, L. and Pinheiro, J. and Wood, J. and Thomas, A. L. and Unger, C. and Henry, A. and Steward, W. P. and Laurent, D. and Lebwohl, D. and Dugan, M. and Marmé, D.. (2005) Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials. Annals of Oncology, 16 (4). pp. 558-565. 2004Medinger, M. and Steinbild, S. and Mross, K.. (2004) Adjuvant and palliative anticancer treatment of colon carcinoma in 2004. PRAXIS, 93 (40). pp. 1633-1644. Drevs, Joachim and Fakler, Julia and Eisele, Silke and Medinger, Michael and Bing, Gerlinde and Esser, Norbert and Marmé, Dieter and Unger, Clemens. (2004) Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy. Anticancer Research, 24 (3). pp. 1759-1763. Medinger, Michael and Soltau, Jens and Unger, Clemens and Drevs, Joachim. (2004) Rezeptor-tyrosinkinasen: Angriffspunkte für neue tumortherapien. Medizinische Monatsschrift für Pharmazeuten, 27 (2). pp. 50-59. 2003Medinger, M. and Adler, C. P. and Schmidt-Gersbach, C. and Soltau, J. and Droll, A. and Unger, C. and Drevs, J.. (2003) Angiogenesis and the ET-1/ETA receptor system: immunohistochemical expression analysis in bone metastases from patients with different primary tumors. Angiogenesis, 6 (3). pp. 225-231. Soltau, Jens and Medinger, Michael and Unger, Clemens and Drevs, Joachim. (2003) Bisphosphonate in der onkologie. Medizinische Monatsschrift für Pharmazeuten, 26 (12). pp. 411-417. Drevs, Joachim and Medinger, Michael and Schmidt-Gersbach, Carmen and Weber, Renate and Unger, Clemens. (2003) Receptor tyrosine kinases: the main targets for new anticancer therapy. Current Drug Targets, 4 (2). pp. 113-121. 2002Drevs, J. and Laus, C. and Medinger, M. and Schmidt-Gersbach, C. and Unger, C.. (2002) Antiangiogenesis: current clinical data and future perspectives. Onkologie, 25 (6). pp. 520-527. |
